Pulmonary embolism with chronic obstructive pulmonary disease.
Pulmonary embolism with chronic obstructive pulmonary disease.
复制标题
肺栓塞合并慢性阻塞性肺疾病
DOI：
10.1016/j.cdtm.2021.04.001
复制
发表时间：
2021-09
影响因子：
--
通讯作者：
Deng C
中科院分区：
文献类型：
--
作者：
Yang R;Liu G;Deng C
慢性阻塞性肺疾病（COPD）是一种常见的、可预防和可治疗的疾病。COPD的发病率在中国每年都在增长，并且是一个显著且不断增长的公共卫生负担。多因素分析显示，COPD是肺栓塞（PE）发生的独立危险因素之一，COPD患者PE的发生率明显高于正常人。但在COPD急性加重期（AECOPD）患者中，PE往往被忽视，因为PE与AECOPD的临床症状有很多相似之处，难以区分，导致治疗不及时，预后差。因此，了解COPD合并PE的临床表现、诊断和治疗，对于更准确的诊断，及时有效的治疗，改善患者预后具有重要意义。
Chronic obstructive pulmonary disease (COPD) is a common, preventable, and treatable disease. The incidence of COPD is growing annually in China, and it is a significant and growing public health burden. Multivariate analysis showed that COPD was one of the independent risk factors for the occurrence of pulmonary embolism (PE), and the incidence of PE was significantly higher in COPD patients than in normal subjects. However, PE is often overlooked in patients with acute exacerbation of COPD (AECOPD) because there are many similarities in clinical symptoms between PE and AECOPD, which are difficult to distinguish, resulting in the failure of timely treatment and poor prognosis. Therefore, it is of great significance to understand the clinical manifestations, diagnosis, and treatment of COPD combined with PE for making a more accurate diagnosis, providing timely and effective treatment, and improving the prognosis of such patients.
影响因子：
0.8
作者：
Hara N;Watanabe K;Miyazaki R;Nakamura T;Lee T;Nagata Y;Nozato T;Miyamoto T;Obayashi T;Ashikaga T
通讯作者：
Ashikaga T
DOI：
10.1177/1076029620937352
发表时间：
2020-01
期刊：
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
影响因子：
--
作者：
Ghazvinian R;Elf J;Löfvendahl S;Holst J;Gottsäter A
通讯作者：
Gottsäter A